Publications While At Healthpartners
Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: a phase III randomized clinical trial
Intranasal delivery of nanoliposomal SN-38 for treatment of diffuse midline glioma
Journal of Neurosurgery.
Baseline comparison of three health utility measures and the feeling thermometer among participants in the Action to Control Cardiovascular Risk in Diabetes trial
Glycaemia and correlates of patient-reported outcomes in ACCORD trial participants
Effect of intensive glycemic lowering on health-related quality of life in type 2 diabetes: ACCORD trial
Economic evaluation of combined diet and physical activity promotion programs to prevent type 2 diabetes among persons at increased risk: a systematic review for the Community Preventive Services Task Force [review, systematic review]
Annals of Internal Medicine.
Long-term impact of intensive glucose, blood pressure, or lipid control on health utility: ACCORDION Study [abstract]
Costs associated with delivering intensive or standard glucose, lipids, and systolic blood pressure control strategies in the ACCORD Trial [abstract]
Intensive glucose, blood pressure, or lipid control had no significant negative impact on health utility or quality-adjusted life years in the ACCORD Trial [abstract]
Map of science